Technology
Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer
Joint initiative to focus on expanding early detection and equitable access to care through lung cancer specific AI workflows on Microsoft's suite of radiology solutions Originally published on BMS.com PRINCETON, NJ / ACCESS Newswire / January 22, ...
About this update from Bristol-myers Squibb Company
[{"type":"text","content":"Joint initiative to focus on expanding early detection and equitable access to care through lung cancer specific AI workflows on Microsoft's suite of radiology solutions","length":173,"tagName":"p"},{"type":"text","content":"Originally published on BMS.com","length":31,"tagName":"p"},{"type":"text","content":"PRINCETON, NJ / ACCESS Newswire / January 22, 2026 / Bristol Myers Squibb (NYSE:BMY, "BMS"), a global leader in oncology, announced an agreement with Microsoft, a market leader in AI-powered radiology and clinical workflow technologies, aiming to accelerate early detection of lung cancer.","length":299,"tagName":"p"},{"type":"text","content":"Through this digital health collaboration, U.S. FDA-cleared radiology AI algorithms will be deployed via Microsoft's Precision Imaging Network, part of Microsoft for Healthcare radiology solutions. Today, more than 80% of hospitals in the U.S. use Microsoft's award-winning network to share medical imaging and access third-party imaging AI. AI capabilities available through Precision Imaging Network can automatically analyze X-ray and CT images to help identify lung disease, supporting radiologists in their daily workflow and helping reduce clinical workload. These advanced AI algorithms can help surface hard to detect lung nodules, potentially identify patients at earlier stages of lung cancer, and help triage them for appropriate care.","length":754,"tagName":"p"},{"type":"text","content":"Lung cancer remains the leading cause of cancer-related deaths in the United States, with approximately 125,000 deaths and 227,000 new cases reported annually. Medically underserved populations experience even higher lung cancer mortality rates and are less likely to receive guideline-concordant screening. With more than half of the patients with incidental findings lost to follow-up, the collaboration leverages workflow management tools to track patients with lung nodules through care pathways and help ensure regular follow-up.","length":534,"tagName":"p"},{"type":"text","content":""By combining Microsoft's highly scalable radiology solutions with BMS' deep expertise in oncology and drug delivery, we've envisioned a unique AI-enabled workflow that helps clinicians quickly and accurately identify patients with Non-Small Cell Lung Cancer (NSCLC) and guide them t...